NeoPharm Co. Ltd.
092730.KQFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
89
Cost of Revenue
34
Gross Profit
56
Gross Margin
62.2%
Operating Income
18
Operating Margin
20.7%
Net Income
17
Net Margin
19.4%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
25
EBITDA Margin
28.0%
2023
12/31/2023
Revenue
73
Cost of Revenue
25
Gross Profit
48
Gross Margin
66.1%
Operating Income
19
Operating Margin
26.1%
Net Income
17
Net Margin
23.9%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
23
EBITDA Margin
31.9%
2022
12/31/2022
Revenue
64
Cost of Revenue
21
Gross Profit
43
Gross Margin
67.4%
Operating Income
16
Operating Margin
25.2%
Net Income
13
Net Margin
20.0%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
19
EBITDA Margin
29.3%
2021
12/31/2021
Revenue
66
Cost of Revenue
20
Gross Profit
46
Gross Margin
69.7%
Operating Income
17
Operating Margin
25.5%
Net Income
13
Net Margin
20.1%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
19
EBITDA Margin
28.8%
2020
12/31/2020
Revenue
61
Cost of Revenue
18
Gross Profit
43
Gross Margin
70.5%
Operating Income
16
Operating Margin
26.8%
Net Income
14
Net Margin
22.2%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
18
EBITDA Margin
29.9%